PureID Medical Technology Co., Ltd, a medical device compliance service provider based in Guangzhou, has reportedly raised over RMB 100 million (USD 13.89 million) in a Series B financing round. The round was led by Legend Capital, with a contribution from existing investor Bayland Capital. The proceeds will be used to support the company’s overseas medical device resource layout, professional talent team expansion, medical device strategy expansion, and big data information platform upgrade and iteration.
Company Background and Services
Founded in 2020, PureID aims to become an industry-leading global SaaS+Data life science service provider. The company offers a comprehensive suite of services, including device regulation consultation, local authorized representative services, product certification and registration, overseas clinical trials, technical documents and system guidance, product testing, and other full-process services. These offerings are designed to support medical device companies in navigating complex regulatory landscapes and achieving compliance.
Future Development Plans
With the new funding, PureID plans to enhance its overseas presence by expanding its medical device resource layout. The company will also focus on growing its professional talent team to better serve its clients. Additionally, PureID will expand its medical device strategy and upgrade its big data information platform to provide more efficient and comprehensive services. These initiatives underscore PureID’s commitment to advancing its position as a leading provider of medical device compliance solutions.-Fineline Info & Tech
